Cost-effectiveness analysis of treating patients with ntrk-positive cancer with the histology-independent therapy entrectinib
<p><strong>Objectives</strong><br> This study tackles several challenges of evaluating histology-independent treatments using entrectinib as an example. Histology-independent treatments are provided based on genetic marker(s) of tumors, regardless of the tumor type. We evalua...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Journal article |
| Language: | English |
| Published: |
Elsevier
2022
|